drugset / Trial / NCT04605458
Contingency Management to Promote Smoking Abstinence in Cancer Patients
Completed
282 enrolled
Medical University of South Carolina
National Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.
Timeline
- Start
- 2020-11-25
- Primary completion
- 2025-07-10
- Completion
- 2025-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Nicotine | Unknown | — | — |
Indications
No indication recorded.